WAP
FLGT icon

Wealthcare Advisory Partners’s Fulgent Genetics FLGT Stock Holding History

Wealthcare Advisory Partners’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,070
Closed -$276K – 607
2022
Q2 		$276K Hold
5,070
– – 0.02% 455
2022
Q1 		$316K Buy
5,070
+200
+4% +$13.2K 0.02% 402
2021
Q4 		$490K Sell
4,870
-60
-1% -$5.27K 0.03% 321
2021
Q3 		$443K Buy
4,930
+125
+3% +$11.4K 0.03% 339
2021
Q2 		$443K Buy
4,805
+2,155
+81% +$172K 0.03% 339
2021
Q1 		$256K Buy
+2,650
New +$274K 0.02% 430
2020
Q2 		– Sell
-120
Closed -$1K – 678
2020
Q1 		$1K Buy
+120
New +$1.67K ﹤0.01% 1392

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealthcare Advisory Partners's FLGT Position: Q3 2022 in Review

Wealthcare Advisory Partners sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 5,070 shares — an estimated $276K sold.

Wealthcare Advisory Partners first reported a position in FLGT in Q1 2020 and held it in 7 quarters. The position peaked at $490K in Q4 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Wealthcare Advisory Partners reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 5,070 Fulgent Genetics shares in Q3 2022, an estimated $276K.
  • Wealthcare Advisory Partners first reported a position in Fulgent Genetics in Q1 2020 and held it in 7 quarters.
  • Wealthcare Advisory Partners's Fulgent Genetics position peaked at $490K in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Wealthcare Advisory Partners's 13F filing for Q3 2022, filed 14 Nov 2022.